Form 8-K - Current report:
SEC Accession No. 0001558370-24-013167
Filing Date
2024-10-07
Accepted
2024-10-07 08:02:34
Documents
44
Period of Report
2024-10-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K viri-20241004x8k.htm   iXBRL 8-K 118497
2 EX-2.1 viri-20241004xex2d1.htm EX-2.1 1429790
3 EX-3.1 viri-20241004xex3d1.htm EX-3.1 109656
4 EX-3.2 viri-20241004xex3d2.htm EX-3.2 9959
5 EX-3.3 viri-20241004xex3d3.htm EX-3.3 227323
6 EX-10.1 viri-20241004xex10d1.htm EX-10.1 123384
7 EX-10.2 viri-20241004xex10d2.htm EX-10.2 108506
8 EX-10.3 viri-20241004xex10d3.htm EX-10.3 29795
9 EX-99.1 viri-20241004xex99d1.htm EX-99.1 53205
10 EX-99.2 viri-20241004xex99d2.htm EX-99.2 35998
11 EX-99.3 viri-20241004xex99d3.htm EX-99.3 42554
12 GRAPHIC viri-20241004xex10d3001.jpg GRAPHIC 6372
13 GRAPHIC viri-20241004xex99d1001.jpg GRAPHIC 4788
14 GRAPHIC viri-20241004xex99d2g001.jpg GRAPHIC 85370
15 GRAPHIC viri-20241004xex99d2g002.jpg GRAPHIC 286471
16 GRAPHIC viri-20241004xex99d2g003.jpg GRAPHIC 172289
17 GRAPHIC viri-20241004xex99d2g004.jpg GRAPHIC 104177
18 GRAPHIC viri-20241004xex99d2g005.jpg GRAPHIC 127297
19 GRAPHIC viri-20241004xex99d2g006.jpg GRAPHIC 167332
20 GRAPHIC viri-20241004xex99d2g007.jpg GRAPHIC 116520
21 GRAPHIC viri-20241004xex99d2g008.jpg GRAPHIC 158640
22 GRAPHIC viri-20241004xex99d2g009.jpg GRAPHIC 112275
23 GRAPHIC viri-20241004xex99d2g010.jpg GRAPHIC 128744
24 GRAPHIC viri-20241004xex99d2g011.jpg GRAPHIC 133669
25 GRAPHIC viri-20241004xex99d2g012.jpg GRAPHIC 92972
26 GRAPHIC viri-20241004xex99d2g013.jpg GRAPHIC 118178
27 GRAPHIC viri-20241004xex99d2g014.jpg GRAPHIC 140583
28 GRAPHIC viri-20241004xex99d2g015.jpg GRAPHIC 146475
29 GRAPHIC viri-20241004xex99d2g016.jpg GRAPHIC 98644
30 GRAPHIC viri-20241004xex99d2g017.jpg GRAPHIC 164075
31 GRAPHIC viri-20241004xex99d2g018.jpg GRAPHIC 119246
32 GRAPHIC viri-20241004xex99d2g019.jpg GRAPHIC 172343
  Complete submission text file 0001558370-24-013167.txt   6472711

Data Files

Seq Description Document Type Size
33 EX-101.SCH viri-20241004.xsd EX-101.SCH 3252
34 EX-101.LAB viri-20241004_lab.xml EX-101.LAB 16582
35 EX-101.PRE viri-20241004_pre.xml EX-101.PRE 10509
46 EXTRACTED XBRL INSTANCE DOCUMENT viri-20241004x8k_htm.xml XML 5038
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Virios Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 241356197
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)